Summary of Key Information:
Reporting Period (Quarter/Year): First quarter and three months ended 30 June 2026 (Q1 FY27)
Nature of Filing / Announcement: Outcome of Board Meeting - Unaudited Financial Results and Corporate Actions
Audit Opinion:
Unmodified opinion (clean) by Kapoor & Parekh Associates, Chartered Accountants (ICAI FRN 104803W)
Auditor’s Comment:
No qualifications or modifications. The limited review report states that nothing has come to their attention that causes them to believe the financial results contain any material misstatement.
Key Financial Highlights [in ₹ Lakhs]:
Standalone Results:
Revenue from Operations: ₹7,397.02 lakhs for Q1 FY27 (compared to ₹7,278.41 lakhs in Q1 FY26)
Total Income: ₹16,135.61 lakhs for Q1 FY27
EBITDA: Not Specified
Net Profit: ₹324.29 lakhs for Q1 FY27 (compared to ₹134.05 lakhs in Q1 FY26)
EPS: Basic ₹0.93, Diluted ₹0.92 for Q1 FY27
Other Equity: ₹10,951.14 lakhs
Cash and Cash Equivaleents: Not Specified
Debt: Not Specified
Consolidated Results:
Not Specified
Segment-wise Performance:
The Company has only one segment of activity namely "Pharmaceuticals".
Corporate Actions:
- Allotment of 27,530 Equity Shares of face value ₹10/- each to eligible employees under Wanbury Limited Employee Stock Option Plan 2016 (WANBURY ESOP 2016)
- Paid-up share capital increased from ₹34,93,93,980 (3,49,39,398 shares) to ₹34,96,69,280 (3,49,66,928 shares)
- Exercise price per share: ₹10/- (Rupees Ten only)
- Total amount realized by exercise of options: ₹2,75,300 (Rupees Two Lakh Seventy Five Thousand Three Hundred only)
- Diluted earnings per share pursuant to issue of equity shares on exercise of options: (₹0.92)
Other Significant Information:
- During the quarter, the Company availed aggregate borrowings of ₹205 crores from non-banking financial companies for repayment of existing high-cost borrowings, capital expenditure and general corporate purposes
- Pursuant to repayment of existing high-cost borrowings, 85,20,330 equity shares pledged by promoters were released on 7 July 2026
- Exceptional items of ₹360.39 Lakhs from previous quarter primarily due to change in definition of "wages" for employees and contract labours pursuant to New Labour Code effective from 21 November 2025